Skip to main content

Animations

MJFF Publications

4951 - 4960 of 6420 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2024
  • 2023
  • 2025
  • 2023
  • 2021
  • 2025
  • 2017
  • 2016
  • Summary Details
    OPEN
    Title: Hydrop enables droplet-based single-cell ATAC-seq and single-cell RNA-seq using dissolvable hydrogel beads
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.7554/elife.73971
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Multimodal assessment of mitochondrial function in Parkinson's disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awad364
    Citation Count: 23
  • Summary Details
    OPEN
    Title: A framework for translating tauopathy therapeutics: Drug discovery to clinical trials
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14250
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Linear ubiquitination induces NEMO phase separation to activate NF-κB signaling
    Journal Name: Life Science Alliance
    Publisher: Life Science Alliance, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.26508/lsa.202201607
    Citation Count: 28
  • Summary Details
    OPEN
    Title: From rodents to humans: Conserved codistribution of dopaminergic with serotonergic neurons in the dorsal raphe nucleus and their molecular characterization
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107173
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43856-023-00294-w
    Citation Count: 30
  • Summary Details
    OPEN
    Title: Contribution of neuropsychiatric symptoms in Parkinson’s disease to different domains of caregiver burden
    Journal Name: Journal of Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00415-021-10443-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Mitochondrial complex I deficiency occurs in skeletal muscle of a subgroup of individuals with Parkinson’s disease
    Journal Name: Communications Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s43856-025-00817-7
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0426-8
    Citation Count: 87
  • Summary Details
    OPEN
    Title: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.17111
    Citation Count: 55
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.